We have a growing mental health crisis, and available treatments are quite limited in their effectiveness. There are 12 million U.S. citizens with PTSD, 20 million with depression, and close to 20 million with substance use disorder.
Psychedelic-assisted therapy offers the most effective mental health treatment ever studied. In MAPS Phase III clinical trials, 67% of trial participants treated with MDMA no longer qualified as having a PTSD diagnosis after suffering for 14 years on average, and 88% saw significant improvement in their symptoms after just three treatments with MDMA-therapy. Similar results are being shown using psilocybin-assisted therapy to treat depression. We invest in cutting-edge research into these compounds, advocacy efforts, equitable access initiatives, education, and delivery of care.
Please explore the work of these incredible organizations: MAPS, Sunstone Therapies, Drugs Over Dinner, Fireside Project, Healing Advocacy Fund, and PSFC, as well as these brilliant scientists: Dr. Nolan Williams at Stanford University, Dr. Roland Girffiths at John Hopkins University, Dr. Alex Lehmann at McGill University, and Dr. Robin Carhart-Harris at UCSF.
Nessun commento:
Posta un commento